Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs MindWalk Holdings Corp. (HYFT)

Champions Oncology, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Champions Oncology, Inc. and MindWalk Holdings Corp. are of similar size ($66.7M and $66.0M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −27.0%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −105.1%) and the lower return on invested capital (−626.2% vs −464.6%). Across the 18 metrics below, Champions Oncology, Inc. leads on 13 and MindWalk Holdings Corp. on 5.

Valuation

Metric CSBR HYFT Biotechnology median
P/E n/m n/m 8.50
P/S 1.08 5.23 9.71
P/B 14.65 12.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 196.33 n/m 0.64
EV/Sales 1.01 5.14 9.21
Earnings yield (1.70%) (19.85%) (33.15%)
Free cash flow yield (9.36%) (14.68%) (25.50%)

Profitability

Metric CSBR HYFT Biotechnology median
Gross margin 49.82% 60.81% 65.16%
Operating margin (1.68%) (103.99%) 0.00%
Net margin (1.87%) (105.06%) 0.00%
Free cash flow margin (10.08%) (76.79%) 0.00%
Return on equity (28.38%) (122.85%) (56.36%)
Return on assets (3.56%) (58.55%) (48.04%)
Return on invested capital (626.23%) (464.59%) 0.00%

Growth

Metric CSBR HYFT Biotechnology median
Revenue growth (TTM) 6.65% (26.99%) 6.02%
EPS growth (last fiscal year) (124.24%) 66.15% 30.26%
Revenue growth, 5-year CAGR 7.68% (3.83%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR HYFT Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 1.03 1.84 4.72
Net debt to EBITDA (20.56) 0.62 0.96

Dividend

Metric CSBR HYFT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSBR HYFT Biotechnology median
Market cap 66.67m 65.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack